Search
Edotreotide
go.drugbank.com/drugs/DB17969InvestigationalSynonyms: L-cysteinamide, n-((4,7,10-tris(carboxymetnyl)-1,4,7,10-tetraazacyclodec-1-yl)acetyl)-d-phenylalanyl-l-cysteinyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-threonyl-n-((1r,2r)-2-hydroxy-1-(hydroxymethyl)propyl)-, N-((4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacycoldodec-1-yl)acetyl-d-phenylalanyl-l-cysteinyl-l-tyrosyl-d-tryprophyl-l-lysyl-l-threonyl-n-((1r,2r)-2-hydroxy-1-(hydroxymethyl)propyl)-l-cysteinamideCategories: Compounds used in a research, industrial, or household settingAtaciguat
go.drugbank.com/drugs/DB12805InvestigationalAtaciguat has been investigated for the basic science of Aortic Valve Stenosis.
Naftopidil
go.drugbank.com/drugs/DB12092InvestigationalNaftopidil has been investigated for the treatment of Disorder of Urinary Stent.
MK-0557
go.drugbank.com/drugs/DB12168InvestigationalMK0557 has been investigated for the treatment of Schizophrenia and Paranoid Schizophrenia.
BMS-863233
go.drugbank.com/drugs/DB12357InvestigationalBMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
Oglemilast
go.drugbank.com/drugs/DB12375InvestigationalOglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.
GSK-1292263
go.drugbank.com/drugs/DB12627InvestigationalGSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
Linopristin
go.drugbank.com/drugs/DB19296ExperimentalThe combination product was under investigation in clinical trials NCT00653172 and NCT00949130 for treatment of various bacterial infections. … Linopristin is an antibiotic of the streptogramin B class. It is one part of the combination product NXL 103, along with [Virginiamycin M1].
TW-37
go.drugbank.com/drugs/DB17059ExperimentalTW-37 is a small-molecule inhibitor of Bcl-2 investigated for its anti-cancer properties.[A253157]
Synonyms: Benzamide, n-(4-((2-(1,1-dimethylethyl)phenyl)sulfonyl)phenyl)-2,3,4-trihydroxy-5-((2-(1-methylethyl)phenyl)methyl)-, N-(4-((2-(1,1-dimethylethyl)phenyl)sulfonyl)phenyl)-2,3,4-trihydroxy-5-((2-(1-methylethyl)phenyl)methyl)benzamideBHT-3034
go.drugbank.com/drugs/DB18045ExperimentalBHT-3034 is a DNA plasmid vaccine immunotherapy under investigation for the treatment of myasthenia gravis.[L48086]